霍奇金淋巴瘤微环境的基因组规模空间映射识别了瘤细胞生存因素
Vignesh Shanmugam1,2,3, Neriman Tokcan1,4, Daniel Chafamo5,6
1Broad Institute of MIT and Harvard, Cambridge, MA, USA.
bioRxiv : the preprint server for biology
|February 3, 2025
概括
研究人员确定了互白素-13 (IL13) 作为霍奇金淋巴瘤 (HL) 细胞的关键生存因素. 用抗体向IL13受体显示出新的HL疗法的前景.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 霍奇金淋巴瘤 (HL) 的特点是复杂的瘤微环境中的恶性霍奇金里德斯特恩伯格 (HRS) 细胞.
- 识别对HRS细胞存活至关重要的分泌因子一直是一个重大挑战.
- 以前的方法缺乏在全基因组范围内分析HL瘤微环境的分辨率.
研究的目的:
- 描述HL瘤微环境的全基因组转录格局.
- 为了确定支持HRS细胞存活的特定联结体受体相互作用.
- 评估针对已识别的生存途径的治疗潜力.
主要方法:
- 具有空间和单细胞分辨率的全基因组转录概况.
- 机器学习在HRS细胞利基中提名丰富的配体-受体对.
- 在体外增殖测定与重组型英特鲁金-13 (IL13).
- 全基因组的CRISPR/Cas9功能丧失屏幕在1000多个癌症细胞系.
- 使用向IL13受体的单克隆抗体的功能研究.
主要成果:
- HRS细胞利基包括31种免疫和树皮细胞类型,富含CD4+T细胞,髓状细胞和卵泡树突细胞.
- 介素-13 (IL13) 被确定为候选生存因子,复合IL13在体外促进HRS细胞增殖.
- IL13受体组件IL4R和IL13RA1对于HRS细胞存活至关重要,由CRISPR/Cas9屏幕和基于抗体的抑制证实.
结论:
- 该研究阐明了细胞组成,并确定IL13是霍奇金淋巴瘤的关键生存因素.
- 准IL13受体通路为HL提供了一个有前途的治疗策略.
- 现有的FDA批准的IL13向抗体需要在霍奇金淋巴瘤患者的临床试验中进行调查.
相关概念视频
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...